{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:44:47Z","timestamp":1790905487319,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.antiviral.2006.04.007","type":"journal-article","created":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T06:20:11Z","timestamp":1146810011000},"page":"172-180","source":"Crossref","is-referenced-by-count":96,"title":["Antiviral therapy for adenovirus infections"],"prefix":"10.1016","volume":"71","author":[{"given":"L.","family":"Lenaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Naesens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2006.04.007_bib1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1081\/NCN-100002508","article-title":"6-Azacytidine\u2014compound with wide spectrum of antiviral activity","volume":"20","author":"Alexeeva","year":"2001","journal-title":"Nucleos. Nucleot. Nucleic Acids"},{"key":"10.1016\/j.antiviral.2006.04.007_bib2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/jm00206a005","article-title":"Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin)","volume":"21","author":"Allen","year":"1978","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2006.04.007_bib3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00006454-200011000-00016","article-title":"Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient","volume":"19","author":"Arav-Boger","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2006.04.007_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/JVI.74.1.42-48.2000","article-title":"Adenovirus type 37 uses sialic acid as a cellular receptor","volume":"74","author":"Arnberg","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib5","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.1128\/JVI.74.16.7691-7693.2000","article-title":"Initial interactions of subgenus D adenoviruses with A549 cellular receptors: sialic acid versus alpha(v) integrins","volume":"74","author":"Arnberg","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0166-3542(01)00197-8","article-title":"Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection","volume":"53","author":"Arnold","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/AAC.31.2.337","article-title":"Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2\u2032-nor-cyclic GMP on adenovirus replication in vitro","volume":"31","author":"Baba","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.04.007_bib8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.bmt.1702716","article-title":"Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation","volume":"26","author":"Baldwin","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib9","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/319984","article-title":"Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Bordigoni","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.04.007_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/oxfordjournals.aje.a121094","article-title":"Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome","volume":"90","author":"Brandt","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1083-8791(03)00102-2","article-title":"Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival","volume":"9","author":"Bruno","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib12","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1096\/fj.03-0396fje","article-title":"Nitric oxide inhibits the adenovirus proteinase in vitro and viral infectivity in vivo","volume":"17","author":"Cao","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.antiviral.2006.04.007_bib13","first-page":"247","article-title":"Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation","volume":"7","author":"Cassano","year":"1991","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib14","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","article-title":"Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery","volume":"100","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2006.04.007_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/viro.1998.9180","article-title":"Mouse adenovirus type-1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice","volume":"245","author":"Charles","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2006.04.007_bib16","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1248\/bpb.26.1600","article-title":"In vitro anti-herpes simplex viruses and anti-adenoviruses activity of twelve traditionally used medicinal plants in Taiwan","volume":"26","author":"Chiang","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.antiviral.2006.04.007_bib17","first-page":"37","article-title":"Severe adenovirus infection in children","volume":"36","author":"Chuang","year":"2003","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.antiviral.2006.04.007_bib18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.bmt.1702656","article-title":"Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit","volume":"26","author":"Crooks","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-3542(99)00070-4","article-title":"Inhibition of herpes simplex virus type 1 and adenovirus type 5 by heterocyclic Schiff bases of aminohydroxyguanidine tosylate","volume":"44","author":"Das","year":"1999","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.16.4.569-596.2003","article-title":"Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections","volume":"16","author":"De Clercq","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2006.04.007_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0166-3542(95)00962-0","article-title":"Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model","volume":"31","author":"de Oliveira","year":"1996","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib22","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/ndt\/gfg365","article-title":"Refractory adenovirus infection after simultaneous kidney\u2013pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin","volume":"18","author":"Emovon","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib23","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.1128\/JVI.76.21.10608-10616.2002","article-title":"Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes","volume":"76","author":"Garnett","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1073\/pnas.88.5.1651","article-title":"A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia","volume":"88","author":"Ginsberg","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2006.04.007_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbmt.2005.06.007","article-title":"Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation","volume":"11","author":"Gorczynska","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib26","first-page":"2774","article-title":"Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir","volume":"37","author":"Gordon","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2006.04.007_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/02713680590934111","article-title":"Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity","volume":"30","author":"Gordon","year":"2005","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00003226-199609000-00018","article-title":"Treatment of adenoviral conjunctivitis with topical cidofovir","volume":"15","author":"Gordon","year":"1996","journal-title":"Cornea"},{"key":"10.1016\/j.antiviral.2006.04.007_bib29","first-page":"574","article-title":"An ocular model of adenovirus type 5 infection in the NZ rabbit","volume":"33","author":"Gordon","year":"1992","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2006.04.007_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0166-3542(91)90054-U","article-title":"Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2\u2032-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro","volume":"16","author":"Gordon","year":"1991","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib31","first-page":"4135","article-title":"Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model","volume":"35","author":"Gordon","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2006.04.007_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib33","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1128\/JVI.69.12.7674-7681.1995","article-title":"Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL\/6 but not BALB\/c mice","volume":"69","author":"Guida","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bmt.1701563","article-title":"Adenovirus infection after pediatric bone marrow transplantation","volume":"23","author":"Hale","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1086\/426831","article-title":"Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro","volume":"191","author":"Hartline","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.04.007_bib36","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archopht.119.10.1487","article-title":"Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study","volume":"119","author":"Hillenkamp","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0161-6420(02)00992-2","article-title":"The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study","volume":"109","author":"Hillenkamp","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.antiviral.2006.04.007_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0166-3542(02)00021-9","article-title":"Adenovirus inhibition by peptidomimetic integrin antagonists","volume":"55","author":"Hippenmeyer","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/bbmt.2001.v7.pm11529489","article-title":"Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation","volume":"7","author":"Hoffman","year":"2001","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib40","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1021\/jm011095y","article-title":"6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity","volume":"45","author":"Holy","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2006.04.007_bib41","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.bmc.2005.05.051","article-title":"Antiviral cyclic d,l-alpha-peptides: targeting a general biochemical pathway in virus infections","volume":"13","author":"Horne","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2006.04.007_bib42","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/313514","article-title":"Adenovirus infections in hematopoietic stem cell transplant recipients","volume":"29","author":"Howard","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.04.007_bib43","first-page":"663","article-title":"Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation","volume":"14","author":"Hromas","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jmv.10475","article-title":"Acute inflammatory response and remodeling of airway epithelium after subspecies B1 human adenovirus infection of the mouse lower respiratory tract","volume":"71","author":"Kajon","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib45","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2141.2005.05649.x","article-title":"Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation","volume":"130","author":"Kampmann","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0166-3542(01)00167-X","article-title":"Antiviral activity of NMSO3 against adenovirus in vitro","volume":"52","author":"Kaneko","year":"2001","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2003.08.003","article-title":"The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir","volume":"61","author":"Kaneko","year":"2004","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-3542(02)00098-0","article-title":"Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir","volume":"56","author":"Kinchington","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib49","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jac\/dki057","article-title":"Prospects for adenovirus antivirals","volume":"55","author":"Kinchington","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2006.04.007_bib50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.24.3.353","article-title":"Broad-spectrum antiviral activity of 2-beta-d-ribofuranosylselenazole-4-carboxamide, a new antiviral agent","volume":"24","author":"Kirsi","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.04.007_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0166-3542(96)06966-5","article-title":"Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method","volume":"31","author":"Kodama","year":"1996","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/rmv.386","article-title":"The impact of adenovirus infection on the immunocompromised host","volume":"13","author":"Kojaoghlanian","year":"2003","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib53","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/319352","article-title":"Adenovirus infections in adult recipients of blood and marrow transplants","volume":"32","author":"La Rosa","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.04.007_bib54","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1086\/420817","article-title":"Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection","volume":"38","author":"Lankester","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.04.007_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2141.2004.05218.x","article-title":"Adenovirus as an emerging pathogen in immunocompromised patients","volume":"128","author":"Leen","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib56","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1702820","article-title":"Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children","volume":"27","author":"Legrand","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib57","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1128\/AAC.49.11.4689-4699.2005","article-title":"Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections","volume":"49","author":"Lenaerts","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.04.007_bib58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bmt.1703798","article-title":"Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation","volume":"31","author":"Ljungman","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib59","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00018-003-2318-2","article-title":"Specific interactions of the adenovirus proteinase with the viral DNA, an 11-amino-acid viral peptide, and the cellular protein actin","volume":"60","author":"Mangel","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.antiviral.2006.04.007_bib60","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/viro.1997.8904","article-title":"Two closely related adenovirus genome types with kidney or respiratory tract tropism differ in their binding to epithelial cells of various origins","volume":"240","author":"Mei","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2006.04.007_bib61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0166-3542(97)01029-2","article-title":"Inhibitory activity of 3\u2032-fluoro-2\u2032 deoxythymidine and related nucleoside analogues against adenoviruses in vitro","volume":"34","author":"Mentel","year":"1997","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004300000046","article-title":"Inhibition of adenovirus DNA polymerase by modified nucleoside triphosphate analogs correlate with their antiviral effects on cellular level","volume":"189","author":"Mentel","year":"2000","journal-title":"Med. Microbiol. Immunol. (Berl)"},{"key":"10.1016\/j.antiviral.2006.04.007_bib63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-3542(00)00088-7","article-title":"Evaluation of the efficacy of 2\u2032,3\u2032-dideoxycytidine against adenovirus infection in a mouse pneumonia model","volume":"47","author":"Mentel","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib64","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.bmt.1702195","article-title":"Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors","volume":"25","author":"Miyamura","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib65","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1128\/JVI.78.11.5584-5590.2004","article-title":"Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase","volume":"78","author":"Moore","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/135965350501000204","article-title":"In vitro susceptibility of adenovirus to antiviral drugs is species-dependent","volume":"10","author":"Morfin","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2006.04.007_bib67","doi-asserted-by":"crossref","first-page":"8917","DOI":"10.1093\/nar\/17.22.8917","article-title":"Mechanism of inhibition of adenovirus DNA replication by the acyclic nucleoside triphosphate analogue (S)-HPMPApp: influence of the adenovirus DNA binding protein","volume":"17","author":"Mul","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib68","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1086\/498151","article-title":"Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients","volume":"41","author":"Muller","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.04.007_bib69","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/514978","article-title":"Disseminated adenovirus disease in immunocompromised and immunocompetent children","volume":"27","author":"Munoz","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.04.007_bib70","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/AAC.49.3.1010-1016.2005","article-title":"Antiadenovirus activities of several classes of nucleoside and nucleotide analogues","volume":"49","author":"Naesens","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.04.007_bib71","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1704682","article-title":"Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients","volume":"34","author":"Nagafuji","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-3542(98)00005-9","article-title":"Activity of N-chlorotaurine against herpes simplex- and adenoviruses","volume":"38","author":"Nagl","year":"1998","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib73","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/01.aids.0000180115.26561.27","article-title":"Adenovirus viraemia and dissemination unresponsive to antiviral therapy in advanced HIV-1 infection","volume":"19","author":"Nebbia","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2006.04.007_bib74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/000348940411300117","article-title":"Tolerability of N-chlorotaurine in the guinea pig middle ear: a pilot study using an improved application system","volume":"113","author":"Neher","year":"2004","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.53.1.157","article-title":"Intracellular metabolism of the N7-substituted acyclic nucleoside analog 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, a potent inhibitor of herpesvirus replication","volume":"53","author":"Neyts","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-5793(01)02672-2","article-title":"Discovery of a new inhibitor lead of adenovirus proteinase: steps toward selective, irreversible inhibitors of cysteine proteinases","volume":"502","author":"Pang","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2006.04.007_bib77","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/AAC.48.2.404-412.2004","article-title":"Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir","volume":"48","author":"Quenelle","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.04.007_bib78","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0166-3542(01)00166-8","article-title":"Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5\/New Zealand rabbit ocular model","volume":"52","author":"Romanowski","year":"2001","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib79","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1086\/341770","article-title":"High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation","volume":"35","author":"Schilham","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.04.007_bib80","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.1128\/JVI.77.17.9183-9191.2003","article-title":"Adenovirus type 11 uses CD46 as a cellular receptor","volume":"77","author":"Segerman","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib81","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of virazole: 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2006.04.007_bib82","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0166-3542(98)00040-0","article-title":"Adenovirus endopeptidase and papain are inhibited by the same agents","volume":"40","author":"Sircar","year":"1998","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib83","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1542\/peds.107.5.e69","article-title":"A syndrome of transient encephalopathy associated with adenovirus infection","volume":"107","author":"Straussberg","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2006.04.007_bib84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/jop.2005.21.157","article-title":"Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis\u2014a double-blind, randomized, phase-2 clinical trial","volume":"21","author":"Teuchner","year":"2005","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2006.04.007_bib85","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/archopht.1992.01080200147043","article-title":"An experimental animal model of adenovirus-induced ocular disease. The cotton rat","volume":"110","author":"Tsai","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejmech.2003.12.002","article-title":"Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus","volume":"39","author":"Uckun","year":"2004","journal-title":"Eur. J. Med. Chem."},{"issue":"93\u2013105","key":"10.1016\/j.antiviral.2006.04.007_bib87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4684-8730-5_9","article-title":"Replication in vitro of adenovirus DNA","volume":"179","author":"van der Vliet","year":"1984","journal-title":"Adv. Exp. Med. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2006.04.007_bib88","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/sj.bmt.1704852","article-title":"Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity","volume":"35","author":"van Tol","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2006.04.007_bib89","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1086\/429235","article-title":"Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary?","volume":"40","author":"Walls","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.04.007_bib90","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-3542(02)00212-7","article-title":"Inhibition of adenovirus infection and adenain by green tea catechins","volume":"58","author":"Weber","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2006.04.007_bib91","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/sj.cgt.7700638","article-title":"Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs","volume":"10","author":"Wildner","year":"2003","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.antiviral.2006.04.007_bib92","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ajo.2005.03.077","article-title":"Vitronectin: a possible determinant of adenovirus type 19 tropism for human corneal epithelium","volume":"140","author":"Xiao","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.antiviral.2006.04.007_bib93","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0166-3542(02)00193-6","article-title":"Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro","volume":"58","author":"Zarubaev","year":"2003","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206001185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206001185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T09:25:44Z","timestamp":1683451544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354206001185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":93,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0166354206001185"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2006.04.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}